Print
Print
Advertisement
Nichole TuckerAcute Myeloid Leukemia | May 15, 2025
Sankalp Arora, MBBS, a second-year fellow at MD Anderson, presented data on FLT3 inhibitors in AML at the HemOnc Pulse Live.
Melissa BadamoPrint | May 14, 2025
Dr. Rogers shares her career trajectory, what being a doctor is about, and a glimpse of her pet guinea pigs, Maple and Brady.
Nichole TuckerMyelodysplastic Syndromes | May 13, 2025
Julie Braish, MBBCh, a third-year fellow at MD Anderson, presented data on azacitidine and venetoclax in HR-MDS and CMML.
Melissa BadamoPrint | May 12, 2025
Experts discuss the link between dietary patterns and blood cancer risk and the shortcomings of epidemiological studies.
Melissa BadamoPrint | May 8, 2025
Dr. Locke is a lead investigator of the ZUMA-1 and ZUMA-7 trials, which led to the FDA approval of axi-cel.
Melissa BadamoPrint | May 7, 2025
The awards recognize early-, mid-, or senior-career experts who display excellence in the field.
Advertisement
Mehdi Hamadani, MDPrint | April 24, 2025
Co-Editor-in-Chief Mehdi Hamadani, MD, reflects on the importance of exchanging ideas and shaping the future of patient care.
Melissa BadamoPrint | April 23, 2025
William Morice, MD, PhD, President and CEO of Mayo Clinic Laboratories, discussed a collaboration to expand cancer testing.
Leah LawrencePrint | April 22, 2025
Experts explore the impact of policy changes directed at the NIH to freeze research funds and terminate grants.
Melissa BadamoPrint | April 16, 2025
Dr. Parekh’s laboratory focuses on developing personalized treatment strategies for patients with multiple myeloma.
Melissa BadamoPrint | April 15, 2025
Douglas Graham, MD, PhD, a hematologist-oncologist specializing in pediatric leukemia, was recognized in Atlanta Magazine.
Melissa BadamoMantle Cell Lymphoma | April 15, 2025
Tycel Phillips, MD, discussed his presentation on BTK inhibitors from the International Ultmann Chicago Lymphoma Symposium.
Melissa BadamoPrint | April 14, 2025
The award provides early-career researchers at NCCN Member Institutions with $150,000 in funding to support cancer research.
Nirav Shah, MD, MSHPTransplantation & Cellular Therapy | April 15, 2025
Nirav Shah, MD, MSHP, recently presented at the International Ultmann Chicago Lymphoma Symposium on this subject.
Nichole TuckerAcute Lymphoblastic Leukemia | April 15, 2025
Joseph G. Jurcic, MD on the journey to survivorship for adults with either AML or ALL.
Melissa BadamoPrint | March 26, 2025
Dr. Richard shares her passion for cellular therapy, how her mother’s leukemia diagnosis shaped her career, and more.
Nichole TuckerAcute Myeloid Leukemia | April 2, 2025
Readmission rates were higher among patients with AML with high incomes compared with patients with low incomes.
Melissa BadamoPrint | March 24, 2025
The award recognizes physician-scientists who made notable research achievements early in their first faculty appointment.
Leah LawrencePrint | March 24, 2025
The FDA approvals of CAR T-cell therapies have changed the treatment landscape for several hematologic malignancies.
Melissa BadamoPrint | February 24, 2025
Dr. Gerds describes his journey to becoming a hematologist oncologist at the Cleveland Clinic.
Advertisement
Advertisement